On Saturday, President Donald Trump signed an executive order expediting federal review of psychedelic drugs for treating mental illness, a class of drugs including LSD, psilocybin “magic” mushrooms and others that are highly illegal. Despite being banned, a wealth of research suggests they can treat intractable mental health problems, which has attracted significant investment from the biotech industry. Those who have been working in the space are split, with some seeing the order as little more than a public relations stunt amid the president’s floundering Iran war, which he launched in late February alongside Israel. Others see the attention as a meaningful change in the government’s approach to drug policy, at least when it comes to psychedelic medical treatments. At the signing on Saturday, Trump was surrounded by the typical coterie of administration officials, such as Health and Human Services Secretary Robert F. Kennedy Jr., a longtime proponent of psychedelics. But one guest stood out from the crowd: podcaster Joe Rogan, who buoyed Trump in the 2024 election and has long supported right-wing causes and …